Dysregulation of IL-6 and IL-10 Gene Expression in Cardiometabolic Syndrome and Heart Failure
Combined assessment of IL-10 gene expression, CRP, and NT-proBNP may improve inflammatory–cardiac risk stratification in CMS and significantly associated with the presence of HF among patients with CMS.